• c-Myc Peptide Workflows for Precision Immunoassays

  2026-08-24

  Use the c-Myc Peptide as a practical competition control for confirming anti-c-Myc specificity, optimizing tagged fusion-protein assays, and separating true biology from detection artifacts. This workflow also shows how lessons from IRF3 stability research can strengthen assay design without implying that the peptide directly regulates antiviral signaling.

• Selective Autophagy Tunes IRF3 Antiviral Signaling

  2026-08-24

  Wu and colleagues show that CALCOCO2/NDP52-dependent selective autophagy controls IRF3 stability according to viral burden, while PSMD14 protects basal IRF3 through deubiquitination. The study connects cargo-selective degradation, ubiquitin-chain editing, and type I interferon output, providing a mechanistic framework for balancing antiviral defense with immune suppression.

• Psora 4: Selective Kv1.3 Blocker Guide

  2026-08-23

  Psora 4 is a small-molecule Kv1.3 blocker for research on T cell Ca2+ signaling and effector-memory T-cell biology. Product data report strong Kv1.3 selectivity, nanomolar inhibition of myelin-specific effector memory T-cell proliferation, and activity in a rat anti-glomerular basement membrane glomerulonephritis model.

• MK-4827 (Niraparib) in DNA Damage Research

  2026-08-22

  MK-4827 (Niraparib) enables controlled PARP-1/-2 inhibition for BRCA-mutant, BRCA-proficient, and radiosensitization studies. This workflow translates recent hyperthermia findings into practical dose-response, DNA repair, apoptosis, and combination assays.

• gamma-Glu-Cys (γ-Glu-Cys): Lab Guide

  2026-08-21

  gamma-Glu-Cys (γ-Glu-Cys) provides a defined intermediate and substrate for glutathione metabolism research, glutathione synthetase enzyme assays, and selected phytochelin-related workflows. It is intended for scientific research only, not diagnostic, clinical, or medical use, and freshly prepared solutions should be used promptly rather than stored long term.

• Formononetin Protects Against Oxaliplatin Neurotoxicity

  2026-08-20

  The reference study identifies formononetin as a neuroprotective isoflavone that reduces oxaliplatin-associated oxidative stress and neuronal apoptosis through the Nrf2/HO-1 pathway. Its central translational contribution is the demonstration that neuronal protection can be achieved without weakening oxaliplatin or paclitaxel activity in tumor-cell models, although protection against paclitaxel-related neurite damage was limited.

• DOM Biphasic Responses: 5-HT2C/1A Modulation

  2026-08-20

  This 2024 mouse study shows that DOM-induced head twitch behavior remains dependent on 5-HT2A receptor activation across its dose range, whereas locomotor effects at high doses follow a different mechanism. Pharmacological evidence implicates 5-HT2C and 5-HT1A receptors, together with PTX-sensitive Gαi/o signaling, in shaping the inverted U-shaped behavioral responses.

• GRK Control of Biased M1 Receptor Signaling

  2026-08-19

  This 2025 study uses time-resolved BRET to define how GRK subtypes regulate M1 muscarinic receptor coupling to G proteins and β-arrestin 2. Its results position the relative activity of GRK2/3 versus GRK5/6 as an important determinant of signaling preference and identify BQCA as a useful probe of M1 receptor allosteric modulation.

• Heparin Sodium in Coagulation and Nanovesicle Research

  2026-08-19

  Heparin sodium provides a controllable anticoagulation benchmark for anti-factor Xa activity assays, activated partial thromboplastin time testing, and thrombosis models. This guide also shows how to use it as a carefully qualified mechanistic control when studying heparan sulfate proteoglycan-mediated uptake of plant-derived nanovesicles.

• Cefodizime BA1050 in Cell Assay Workflows

  2026-08-18

  Learn how Cefodizime SKU BA1050 can be incorporated into cell viability, proliferation, cytotoxicity, and bacterial co-culture workflows without confusing antimicrobial effects with direct mammalian-cell responses. This scenario-based guide connects product specifications with resistance data, solvent controls, protocol design, and practical supplier selection.

• D-Luciferin Sodium Salt for CAR-M Assays

  2026-08-18

  D-Luciferin sodium salt turns firefly luciferase expression into a dynamic readout of CAR-macrophage performance. This guide explains how to interpret ATP-dependent light signals, connect them to the latest CAR-M biology, and design more defensible oncology assays.

• Z-VAD-FMK at the Cell-Death Decision Point

  2026-08-17

  Z-VAD-FMK is more than a pan-caspase inhibitor: it is a strategic perturbation tool for distinguishing apoptotic signaling from ferroptotic and other caspase-independent outcomes. This article connects its mechanism and workflow use to recent findings on σ1R, mitochondria-associated membranes, and ferroptosis.

• Streptavidin-FITC for Glycan Adhesion Assays

  2026-08-17

  Streptavidin-FITC provides a modular route for visualizing biotinylated targets in glycan-dependent bacterial adhesion studies. This article translates ST3GAL1–Fusobacterium nucleatum findings into practical assay-design decisions for imaging, tissue analysis, and flow cytometry.

• LY2109761: A TGF-β Assay Decision Framework

  2026-08-16

  LY2109761 is a TGF-β receptor type I and II dual inhibitor suited to dissecting receptor-level control of Smad signaling, EMT, and tumor-cell behavior. This article connects its biochemical profile with pancreatic cancer assay design and the Wnt/TGF-β findings of a 2025 study.

• 0.4% Trypan Blue Solution: Practical Guide

  2026-08-15

  0.4% Trypan Blue Solution supports direct live/dead cell discrimination, routine cell counting, and membrane-integrity-based cell viability measurement in research workflows. It is intended for cell culture and cytotoxicity assays, but not for diagnostic, therapeutic, or other medical use.

8495 records 1/567 page Next 12345 下5页 Last page